FDA probes deaths of two patients on Lilly schizophrenia drug

(Reuters) - The U.S. Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co.'s long-acting treatment for schizophrenia, Zyprexa Relprevv.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news